AstraZeneca’s experimental drug disappoints in breast cancer survival trial

AstraZeneca said its experimental precision drug, developed with Japan's Daiichi Sankyo, significantly improved overall survival for patients with a type of breast cancer in a late-stage trial. However, overall survival…

WeiterlesenAstraZeneca’s experimental drug disappoints in breast cancer survival trial